Viking Therapeutics, Inc. (VKTX)

34.09 +0.71 (+2.13%) USD  |  NASDAQ  |  Jan 22, 16:00
34.32 +0.23 (+0.67%) After-Hours: 16:39
More

Viking Therapeutics Amortization Expense CF (Quarterly)

Amortization Expense CF (Quarterly) Chart

View Amortization Expense CF (Quarterly) for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (Quarterly) Range, Past 5 Years

View Amortization Expense CF (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (Quarterly) Benchmarks

View Amortization Expense CF (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Altimmune, Inc. --
Moderna, Inc. Upgrade